FOXD2 and cholangiocarcinoma: As shown in Figure 7A, FOXD2-AS1 was overexpressed in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), esophageal carcinoma (ESCA), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), skin cutaneous melanoma (SKCM), stomach adenocarcinoma (STAD), and thymoma (THYM), determining using a |log2FC| cutoff > 1 and a q-value < 0.01.